Marksons Pharma voluntarily recalls a batch of Metformin XR tablets

It is due to the detection of NDMA

Marksans Pharma has issued a voluntary recall of one batch of Metformin Extended-Release Tablets USP 500 mg (11279 bottles, Lot No. XP9004), informed the company through a statement.

It is due to the detection of NDMA as a matter of abundant precaution.

Metformin Extended-Release Tablets USP500 mg is indicated as an adjunct to diet and exercise to improve blood glucose control in adults with type 2 diabetes mellitus.

diabetes drugdrug recallMarksans PharmaMetforminNDMAvoluntary recall
Comments (0)
Add Comment